IMMX - Immix Biopharma, Inc. Common Stock

Immix Biopharma, Inc. (IMMX)

NCM · Common · CUSIP 45258H106

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IMMX and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 45258H106
Market Cap: Micro Cap
IPO: 12/16/2021 · $5.00/share

Links: Home Page Investor Relations News

Business: Immix Biopharma, Inc. clinical-stage biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx), which we believe will replace first-line therapies across a multitude of cancer indications.

Company Contact

CEO: Ilya Rachman
CFO: Gabriel Morris
Headquarters: 11400 West Olympic Blvd., Suite 200, Los Angeles, CA 90064
Phone: 310-651-8041 · Toll-Free 888-958-1084
Investor Relations: Gabriel Morris · 888-958-1084 · ir@immixbio.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »